PP-002Thymosin fragment
TB-500
Thymosin Beta-4 Fragment
Sequence
LKKTETQ
MW
889.04 g/mol
Purity
99.11%
138in stock
§ PP-001Pentadecapeptide
BPC-157
Body Protective Compound
Gastric pentadecapeptide. Synthesised and freeze-dried under inert argon. Isolated for its structural simplicity and synthetic accessibility, BPC-157 is produced as a lyophilised solid and sealed under inert atmosphere.
Every batch moves through the full Six-Step protocol — solid-phase Fmoc synthesis, TFA cleavage, reverse-phase HPLC purification, and ESI-TOF mass-spec confirmation. The lot shipped carries ≥ 99.42% HPLC-MS purity with residual solvent and endotoxin assays signed by an independent laboratory.
Lyophilised vials are stable at −20 °C in their sealed amber container. In bacteriostatic water, HPLC-verified purity holds for approximately four weeks under refrigeration; single-thaw only.
- Sequence
- GEPPPGKPADDAGLV
- Molecular weight
- 1419.53 g/mol
- Purity (HPLC-MS)
- 99.42%
- Dose · fill
- 10 mg
- Lot number
- A-4418
- CoA date
- 2026-03-14
- Storage
- −20 °C · thaw once
- Shipping
- Cold-chain, 1-day overnight
REC · 00:00:08
Spec. PP-001
Lot A-4418
Subject
BPC-157 · 10 mg · lyophilised
MW
1419.53 g/mol
Fig. — Amber borosilicate vial, argon-flushed, 10 mg fill.
Specifications
- Lot
- A-4418
- Dose
- 10 mg
- In stock
- 214 vials
- Dispatch
- Within 24h
- Storage
- −20 °C · thaw once
Price
Ships in 1–2 business days
